{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T05:14:52Z","timestamp":1792300492076,"version":"4.4.0"},"reference-count":24,"publisher":"Japan Endocrine Society","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2009]]},"DOI":"10.1507\/endocrj.k08e-145","type":"journal-article","created":{"date-parts":[[2009,3,12]],"date-time":"2009-03-12T05:56:17Z","timestamp":1236837377000},"page":"17-27","source":"Crossref","is-referenced-by-count":16,"title":["Serum Concentrations of BNP and ANP in Patients with Thyrotoxicosis"],"prefix":"10.1507","volume":"56","author":[{"given":"Keiko","family":"KATO","sequence":"first","affiliation":[{"name":"Department of Endocrinology, Clinical Institute of Endocrinology, Tokyo Women's Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitomi","family":"MURAKAMI","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Clinical Institute of Endocrinology, Tokyo Women's Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"ISOZAKI","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Clinical Institute of Endocrinology, Tokyo Women's Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshio","family":"TSUSHIMA","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Clinical Institute of Endocrinology, Tokyo Women's Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazue","family":"TAKANO","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Clinical Institute of Endocrinology, Tokyo Women's Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"386","reference":[{"issue":"9","key":"1","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1055\/s-2007-978782","volume":"31","author":"CLERICO A","year":"1999","ISSN":"https:\/\/id.crossref.org\/issn\/0018-5043","issn-type":"print"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Boomsma F, Van den Meiracker AH (2001) Plasma A- and B-type peptides: physiology, methodology, and clinical use. <i>Cardiovasc Res<\/i> 51: 442-449.","DOI":"10.1016\/S0008-6363(01)00195-X"},{"key":"3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199807303390507"},{"key":"4","doi-asserted-by":"publisher","DOI":"10.1016\/0006-291X(86)90544-9"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Dietz JR (1984) Release of a natriuretic factor from rat heart-lung preparation by atrial distension. <i>Am J Physiol<\/i> 247: R1093-1096.","DOI":"10.1152\/ajpregu.1984.247.6.R1093"},{"issue":"5","key":"6","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1507\/endocrj1954.37.665","volume":"37","author":"TAJIRI J","year":"1990","ISSN":"https:\/\/id.crossref.org\/issn\/0013-7219","issn-type":"print"},{"issue":"2","key":"7","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1507\/endocrj1954.35.343","volume":"35","author":"YAMAJI T","year":"1988","ISSN":"https:\/\/id.crossref.org\/issn\/0013-7219","issn-type":"print"},{"issue":"6","key":"8","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1507\/endocrj1954.35.907","volume":"35","author":"SUZUKI Y","year":"1988","ISSN":"https:\/\/id.crossref.org\/issn\/0013-7219","issn-type":"print"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Shigematsu S, Iwasaki T, Aizawa T, Ishihara M, Shinoda T, Yamada T, Sato A, Takemura Y (1998) Plasma atrial natriuretic peptide, plasma renin activity and aldosterone during treatment of hyperthyroidism due to Graves' disease. <i>Horm Metab Res<\/i> 21: 514-518.","DOI":"10.1055\/s-2007-1009274"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Czekalski S, Widecka K, Gozdzik J, Ciechanowski K, Krzyzanowska-Swiniarska B, Gromniak E, Gruszczynska M (1994) Atrial natriuretic peptide and cyclic guanosine monophosphate plasma concentrations in patients with thyrotoxicosis and atrial fibrillation. Effect of short-term methimazole therapy. <i>J Endocrinol Invest<\/i> 17: 341-346.","DOI":"10.1007\/BF03348996"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Koukoulis G, Polymeris A, Tzavara I, Pappas D, Thalassinos N (2002) Normalization of thyroid hormone levels in patients with either hyper- or hypothyroidism results in a profound change of atrial natriuretic peptide (ANP) levels. <i>Hormones (Athens)<\/i> 1: 104-112.","DOI":"10.14310\/horm.2002.1158"},{"key":"12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp020057"},{"key":"13","doi-asserted-by":"publisher","DOI":"10.1172\/JCI118162"},{"key":"14","doi-asserted-by":"publisher","DOI":"10.1172\/JCI115146"},{"key":"15","doi-asserted-by":"publisher","DOI":"10.1053\/euhj.2001.2783"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Piuhola J, Szokodi I, Ruskoaho H (2007) Endothelin-I and angiotensin II contribute to BNP but not c-fos gene expression to elevated load in isolated mice hearts. <i>Biochem<\/i> <i> Biophys Acta<\/i> 1772: 338-344.","DOI":"10.1016\/j.bbadis.2006.11.004"},{"key":"17","doi-asserted-by":"publisher","DOI":"10.1042\/BJ20070629"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Ma KK, Ogawa T, de Bold AJ (2004) Selective regulation of cardiac brain natriuretic peptide at transcriptional and translational levels by pro-inflammatory cytokines and by conditioned medium derived from mixed lymphocyte reactions via p38 MAP kinase. <i>J Mol Cell Cardio<\/i> 36: 505-513.","DOI":"10.1016\/j.yjmcc.2004.01.001"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Liang F, Webb P, Marimuth A, Zhang S, Gardner DG (2005) Triiodothyronine increases brain natriuretic peptide (BNP) gene transcription and amplifies endothelin dependent BNP gene transcription and hypertrophy in neonatal rat ventricular myocytes. <i>J Biol Chem<\/i> 278: 15073-15083.","DOI":"10.1074\/jbc.M207593200"},{"key":"20","doi-asserted-by":"publisher","DOI":"10.1016\/0026-0495(93)90023-H"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Schultz M, Faber J, Kistorp C, Jarl&oslash;v A, Pedersen F, Wiinberg N, Hildebrandt P (2004) N-terminal-pro-B-type natriuretic peptide (NT-pro-BNP) in different thyroid function states. <i>Clin Endocrinol (Oxf)<\/i> 60: 54-59.","DOI":"10.1111\/j.1365-2265.2004.01941.x"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Wei T, Zeng C, Tian Y, Chen Q, Wang L (2005) B-type natriuretic peptide in patients with clinical hyperthyroidism. <i>J Endocrinol Invest<\/i> 28: 8-11.","DOI":"10.1007\/BF03345522"},{"issue":"11","key":"23","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1055\/s-2007-979105","volume":"29","year":"1997","ISSN":"https:\/\/id.crossref.org\/issn\/0018-5043","issn-type":"print"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Tanaka T, Kanda T, Takahashi T, Saegusa S, Moriya J, Kurabayashi M (2004) Interleukin-6-induced reciprocal expression of SERCA and natriuretic peptides mRNA in cultured rat ventricular myocytes. <i>Int Med Res<\/i> 32: 57-61.","DOI":"10.1177\/147323000403200109"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/endocrj\/56\/1\/56_K08E-145\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T06:49:13Z","timestamp":1618296553000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/endocrj\/56\/1\/56_K08E-145\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.k08e-145","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009]]}}}